---
figid: PMC7798015__12079_2020_602_Fig2_HTML
figtitle: Complex regulation of CCN2 expression, and the diverse actions of the CCN2
  protein, as reported in literature
organisms:
- NA
pmcid: PMC7798015
filename: 12079_2020_602_Fig2_HTML.jpg
figlink: pmc/articles/PMC7798015/figure/Fig2/
number: F2
caption: 'Overview of the complex regulation of CCN2 expression, and the diverse actions
  of the CCN2 protein, as reported in literature. Regulation of CCN2 expression. a
  Factors inducing CCN2 expression include growth factors, coagulation factors, hormones,
  bioactive lipids, glucose metabolism related factors, hypoxia and mechanical stress.
  b Factors inhibiting CCN2 expression include increased levels of cyclic adenosine
  monophosphate (cAMP), cytokines, insulin‐like growth factor binding protein‐4 (IGFBP-4),
  CCN3 and hepatic growth factor. c CCN2 expression is modified by posttranscriptional
  and posttranslational factors, which includes splicing, regulation by miRNAs, glycosylation,
  proteolytic cleavage and multimerisation of the protein. d CCN2 can induce its own
  expression by auto-induction, resulting in a positive feedback loop. Actions of
  the CCN2 protein: CCN2 exerts its function by binding to growth factors and cell
  surface receptors, thereby affecting intracellular signaling, as well as by binding
  to extracellular matrix (ECM) and other proteins. e CCN2 binds to growth-differentiation
  factor 5 (GDF-5), platelet derived growth factor (PDGF), insulin-like growth factor-1
  and 2 (IGF1/2) and transforming growth factor-β (TGF-β). The effect of CCN2 on the
  binding of these ligands to their putative receptors is not fully elucidated. f
  CCN2 binds to bone morphogenetic proteins (BMPs), vascular endothelial growth factors
  (VEGFs) and fibroblast growth factor 2 (FGF2), thereby modulating their presentation
  and binding to cell-surface receptors, resulting in inhibited signal transduction.
  *Only full-length CCN2 inhibits VEGFA and VEGFC, not its proteolytic fragments.
  g CCN2 binds directly to structural ECM proteins, matricellular proteins and other
  proteins, including aggrecan, fibronectin, decorin, perlecan, CCN3, heparin, Wnt
  inhibitory factor 1 (Wif-1), Slit guidance ligand 3 (Slit-3), and von Willebrand
  factor (vWF). h CCN2 can bind directly to cell surface receptors, which include
  heparan sulphate proteoglycans (HSPGs), tropomyosin receptor kinase A (TrkA), dendritic
  cell-specific transmembrane protein (DC-STAMP), integrins, insulin-like growth factor
  2 receptor (IGF-2R), epidermal growth factor receptor (EGFR), formyl peptide receptor-like
  1 (FPRL1), osteoprotegerin (OPG), lipoprotein receptor-related proteins (LRPs),
  receptor activator of NF-κB (RANK), and fibroblast growth factor receptors (FGFRs).
  By CCN2 binding, intracellular signaling pathways and their cross-talk can be altered
  and gene transcription affected. i Intracellular signaling pathways that are affected
  by CCN2 include the extracellular signal–regulated kinase 1 and 2 (ERK1/2) pathway,
  the Rho GTPase pathway, the WNT pathway, the c-Jun N-terminal kinase (JNK) pathway,
  the phosphatidylinositol 3‑kinase (PI3K)/AKT pathway and the nuclear factor κB (NFκB)
  pathway the signaling mother against dexapentaplegic peptides (Smad) pathway. j
  CCN2 has been reported to act intracellularly after being taken up into the cytosol
  via endocytic pathways and, after phosphorylation, into the nucleus where it may
  affect gene transcription'
papertitle: CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment,
  normal and malignant hematopoiesis.
reftext: Roos J. Leguit, et al. J Cell Commun Signal. 2021 Jan 11 ;15(1):25-56.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9377991
figid_alias: PMC7798015__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7798015__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7798015__12079_2020_602_Fig2_HTML.html
  '@type': Dataset
  description: 'Overview of the complex regulation of CCN2 expression, and the diverse
    actions of the CCN2 protein, as reported in literature. Regulation of CCN2 expression.
    a Factors inducing CCN2 expression include growth factors, coagulation factors,
    hormones, bioactive lipids, glucose metabolism related factors, hypoxia and mechanical
    stress. b Factors inhibiting CCN2 expression include increased levels of cyclic
    adenosine monophosphate (cAMP), cytokines, insulin‐like growth factor binding
    protein‐4 (IGFBP-4), CCN3 and hepatic growth factor. c CCN2 expression is modified
    by posttranscriptional and posttranslational factors, which includes splicing,
    regulation by miRNAs, glycosylation, proteolytic cleavage and multimerisation
    of the protein. d CCN2 can induce its own expression by auto-induction, resulting
    in a positive feedback loop. Actions of the CCN2 protein: CCN2 exerts its function
    by binding to growth factors and cell surface receptors, thereby affecting intracellular
    signaling, as well as by binding to extracellular matrix (ECM) and other proteins.
    e CCN2 binds to growth-differentiation factor 5 (GDF-5), platelet derived growth
    factor (PDGF), insulin-like growth factor-1 and 2 (IGF1/2) and transforming growth
    factor-β (TGF-β). The effect of CCN2 on the binding of these ligands to their
    putative receptors is not fully elucidated. f CCN2 binds to bone morphogenetic
    proteins (BMPs), vascular endothelial growth factors (VEGFs) and fibroblast growth
    factor 2 (FGF2), thereby modulating their presentation and binding to cell-surface
    receptors, resulting in inhibited signal transduction. *Only full-length CCN2
    inhibits VEGFA and VEGFC, not its proteolytic fragments. g CCN2 binds directly
    to structural ECM proteins, matricellular proteins and other proteins, including
    aggrecan, fibronectin, decorin, perlecan, CCN3, heparin, Wnt inhibitory factor
    1 (Wif-1), Slit guidance ligand 3 (Slit-3), and von Willebrand factor (vWF). h
    CCN2 can bind directly to cell surface receptors, which include heparan sulphate
    proteoglycans (HSPGs), tropomyosin receptor kinase A (TrkA), dendritic cell-specific
    transmembrane protein (DC-STAMP), integrins, insulin-like growth factor 2 receptor
    (IGF-2R), epidermal growth factor receptor (EGFR), formyl peptide receptor-like
    1 (FPRL1), osteoprotegerin (OPG), lipoprotein receptor-related proteins (LRPs),
    receptor activator of NF-κB (RANK), and fibroblast growth factor receptors (FGFRs).
    By CCN2 binding, intracellular signaling pathways and their cross-talk can be
    altered and gene transcription affected. i Intracellular signaling pathways that
    are affected by CCN2 include the extracellular signal–regulated kinase 1 and 2
    (ERK1/2) pathway, the Rho GTPase pathway, the WNT pathway, the c-Jun N-terminal
    kinase (JNK) pathway, the phosphatidylinositol 3‑kinase (PI3K)/AKT pathway and
    the nuclear factor κB (NFκB) pathway the signaling mother against dexapentaplegic
    peptides (Smad) pathway. j CCN2 has been reported to act intracellularly after
    being taken up into the cytosol via endocytic pathways and, after phosphorylation,
    into the nucleus where it may affect gene transcription'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCN2
  - GDF5
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - MAPK3
  - MAPK1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - TGFB1
  - TGFB2
  - TGFB3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - FGF13
  - NTRK1
  - DCSTAMP
  - IGFBP4
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - CCN3
  - IGF2R
  - EGFR
  - FPR2
  - WIF1
  - SLIT3
  - TNFRSF11A
  - VWF
  - Glucose
---
